Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Race Oncology Ltd. ( (AU:RAC) ) is now available.
Race Oncology Ltd announced the cessation of 558,040 securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This cessation may impact the company’s capital structure and could have implications for its stakeholders, reflecting on its operational and strategic positioning within the biotechnology sector.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies.
Average Trading Volume: 134,324
Technical Sentiment Signal: Sell
Current Market Cap: A$222.4M
For a thorough assessment of RAC stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue